Virbac S.A.

VRBCF

$383.25

Updated: 24/09/2026, 01:56:10

Market Cap

$3.21B

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

Stock valuation chart

One-year closing share-price history for VRBCF

Company Profile

Virbac S.A. is a leading global animal health company that develops, produces, and distributes a comprehensive array of products and services designed for both domestic pets and livestock. The company maintains a significant international presence, operating across numerous regions including France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. Its extensive portfolio encompasses solutions for disease prevention (such as vaccines), oral hygiene, reproductive health, dermatological conditions, parasite control, and diagnostics. Additionally, Virbac supplies various veterinary pharmaceuticals, including antibiotics, specialized medications for anesthesia, geriatric care, and behavioral issues, as well as injectable micronutrients and aquaculture products. The company also offers animal nutrition products (pet food) and electronic identification systems. Virbac primarily serves the needs of veterinarians, farmers, and individual pet owners. Established in 1968, the company is headquartered in Carros, France.

USD

OTC

CEO: Paul Martingell

Employees: 6,442

https://corporate.virbac.com

Asset Summaries

Latest generated summaries for VRBCF

No summaries found.

Detailed business

Structured knowledge from the latest official annual filing.

No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.

Full company information

Latest profile, trading, valuation, and identifier data stored for VRBCF.

Share price: $383.25
Market cap: $3.21B
Exchange: OTC
Currency: USD
CEO: Paul Martingell
Employees: 6,442
IPO date: 17/04/2013
Beta: 0.776
Last dividend: $0.00
Day range: $383.25 – $431.80
52-week range: $346.00 – $431.80
1-day performance: 0.00%
1-year performance: 10.77%
Current drawdown (1Y): -11.24%
CIK: 0002029969
CUSIP: F97900116
ISIN: FR0000031577
Created: 07/12/2025, 15:00:49
Last update: 24/09/2026, 01:56:10

Track Virbac S.A. with an AI analyst

See which prediction-market events move VRBCF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Create a free account See what the world decides next

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News

News linked to VRBCF from your Railway `news_articles` table.

Virbac : Declaration of the number of shares and voting rights 05/2026

GlobeNewsWire • STOCK • 08/06/2026, 09:53:00

Virbac : Declaration of the number of shares and voting rights 04/2026

GlobeNewsWire • STOCK • 07/05/2026, 06:11:00

Virbac : Public release of Virbac Annual Report at 31 December 2025.

GlobeNewsWire • STOCK • 27/04/2026, 14:30:00

Virbac: strong Q1 2026 growth of +7.7% at CERS, driven by double-digit growth of our priority Supercharge4 platforms

GlobeNewsWire • STOCK • 16/04/2026, 13:45:00

Virbac : Declaration of the number of shares and voting rights 03/2026

GlobeNewsWire • STOCK • 07/04/2026, 07:06:00

Virbac SA (VRBCF) Q4 2025 Earnings Call Transcript

Seeking Alpha • STOCK • 18/03/2026, 18:12:23

Virbac: Public Release of the Year-End Consolidated Accounts at 31 December 2025

GlobeNewsWire • STOCK • 17/03/2026, 15:00:00

Virbac: 2025 annual results

GlobeNewsWire • STOCK • 17/03/2026, 13:45:00

Virbac : Declaration of the number of shares and voting rights 02/2026

GlobeNewsWire • STOCK • 10/03/2026, 14:10:00

Virbac : Declaration of the number of shares and voting rights 01/2026

GlobeNewsWire • STOCK • 05/02/2026, 12:29:00